alprazolam has been researched along with triazolam in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (32.14) | 18.7374 |
1990's | 25 (29.76) | 18.2507 |
2000's | 19 (22.62) | 29.6817 |
2010's | 11 (13.10) | 24.3611 |
2020's | 2 (2.38) | 2.80 |
Authors | Studies |
---|---|
Gall, M; Hester, JB; Lahti, RA; Rudzik, AD | 1 |
Chidester, C; Duchamp, DJ; Gall, M; Lahti, RA; Rudzik, AD; Scahill, T | 1 |
Collins, RJ; Gall, M; Kamdar, BV | 1 |
Hester, JB; Von Voigtlander, P | 1 |
Carroll, ML; Johnson, BD; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Trova, MP; Wissner, A | 1 |
Carroll, ML; Green, KE; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Wissner, A; Wrenn, S | 1 |
Bock, MG; Chang, RS; DiPardo, RM; Evans, BE; Freidinger, RM; Lotti, VJ; Rittle, KE; Veber, DF | 1 |
Fujishita, T; Hirai, K; Hirose, K; Ishiba, T; Matsutani, S; Sugimoto, H; Tsukinoki, Y | 1 |
Carroll, ML; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Trova, MP; Wissner, A | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Bracher, F; Fedorov, O; Filippakopoulos, P; Keller, M; Knapp, S; Morgenstern, O; Picaud, S; Wrobel, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Adam, K; Oswald, I | 2 |
Loeffler, PM | 1 |
Platt, D; Rieck, W | 1 |
Beck, O; Borg, S; Hjemdahl, P; Lafolie, P; Odelius, G; Wirbing, P | 1 |
Franklin, SR; Tang, AH | 1 |
Ellinwood, EH; Gupta, SK; Heatherly, DG; Nikaido, AM | 1 |
Krsiak, M; Sulcova, A | 1 |
Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Pieri, L; Schoch, P | 1 |
Burkhart, KK; Kulig, KW | 1 |
Covington, EC; Rapport, DJ | 1 |
Jones, CE; Martinez, LA; Merritt, GJ; Wians, FH | 1 |
Kozlowski, MR | 1 |
Greenblatt, DJ; Lopez, F; Miller, LG; Paul, SM; Shader, RI | 1 |
Clow, A; Glover, V; Sandler, M | 1 |
Desager, JP; Harvengt, C; Hulhoven, R; Pourbaix, S; Smith, RB | 1 |
Ellinwood, EH; Heatherly, DG; Nikaido, AM | 1 |
Albeck, JH | 1 |
Barnhill, JG; Deutsch, SI; Greenblatt, DJ; Miller, LG; Paul, SM; Shader, RI | 1 |
Obata, T; Yamamura, HI | 1 |
Metys, J; Sulcová, A | 1 |
Patterson, WM | 1 |
Cagen, LM; Chesney, CM; Pifer, DD | 1 |
Casals-Stenzel, J | 1 |
Cox, CP; Wood, KL | 1 |
Divoll, M; Greenblatt, DJ; Moschitto, LJ; Shader, RI | 1 |
Harris, DW; Sethy, VH | 1 |
Abernethy, DR; Divoll, M; Greenblatt, DJ; Harmatz, JS; Moschitto, LJ; Shader, RI | 1 |
Ator, NA; Brady, JV; Griffiths, RR; Lamb, RJ; Lukas, SE | 1 |
Juhl, RP; Kroboth, PD; Phillips, JP; Smith, RB; Stoehr, GP; Wender, DB | 1 |
Ehrlich, YH; Kornecki, E; Lenox, RH | 1 |
Needleman, SB; Porvaznik, M | 1 |
Andrenyak, DM; Huang, W; Moody, DE; Rollins, DE | 1 |
Feuerstein, G; Friedman, E; Wang, HY; Yue, TL | 1 |
Gardner, CR; Laskin, DL; Laskin, JD | 1 |
Barbarito, EJ; Falk, JL; Lau, CE | 1 |
Barbhaiya, R; Chaikin, PC; Folan, MM; Kroboth, PD; Lush, RM; Salazar, DE; Shukla, UA | 1 |
Asahi, T; Kuribara, H | 1 |
Kroboth, PD; McAuley, JW | 1 |
Furukori, H; Hayashi, K; Kaneko, S; Nagasaki, T; Ohkubo, T; Otani, K; Sugawara, K; Tasaki, H; Yasui, N | 1 |
Corbett, K; Counihan, M; Ehrenberg, BL; Greenblatt, DJ; Harmatz, JS; Harrel, LM; Shader, RI; Tobias, S; von Moltke, LL; Wright, CE | 1 |
Daily, JP; Greenblatt, DJ; Harmatz, JS; Shader, RI; von Moltke, LL | 1 |
Balian, JD; Flockhart, DA; Yuan, R | 1 |
Bickel, WK; Smith, BJ | 1 |
Gomez, TH; Meisch, RA; Roache, JD | 1 |
Cantrell, VE; Eckstein, J; Hall, SD; Hamman, MA; Jones, DR; Ring, BJ; Ruterbories, K; Williams, JA; Wrighton, SA | 1 |
Gu, JK; Sun, L; Xia, R; Zhong, DF | 1 |
Kulkarni, SK; Kumar, A | 1 |
Masica, AL; Mayo, G; Wilkinson, GR | 1 |
Jiang, Z; Tan, J; Tao, G; Xing, L; Yao, L; Zhang, Q; Zhu, Y | 1 |
Benet, LZ | 1 |
Dickson, SJ; Irving, RC | 1 |
Galetin, A; Hallifax, D; Houston, JB | 1 |
Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
Hanioka, N; Kuze, J; Morisaki, K; Mutoh, T; Nakura, H; Narimatsu, S; Takenaka, T | 1 |
Chronister, CW; Goldberger, BA; Merves, ML | 1 |
Marin, SJ; McMillin, GA | 1 |
Barter, ZE; Cubitt, HE; Howgate, EM; Rostami-Hodjegan, A; Yeo, KR | 1 |
Arima, Y; Nagao, M; Namera, A; Shiraishi, H; Tajima, T; Torikoshi, A; Toubou, H | 1 |
In, MK; Jeong, YD; Kim, JY; Kim, MK; Paeng, KJ; Suh, SI | 1 |
Hasegawa, M; Tahara, H; Watanabe, M | 1 |
Al-Otaibi, JS | 1 |
Gui, L; Hu, Y; Jia, W; Lan, K; Liu, C; Miao, J; Wang, C; Wei, W; Wu, Q; Zeng, W | 1 |
7 review(s) available for alprazolam and triazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Clonazepam; Diazepam; Drug Tolerance; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1987 |
Progesterone: does it affect response to drug?
Topics: Alprazolam; Contraceptives, Oral; Drug Interactions; Female; Humans; Lorazepam; Middle Aged; Progesterone; Receptors, GABA-A; Temazepam; Triazolam | 1997 |
Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.
Topics: Acquired Immunodeficiency Syndrome; Alprazolam; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; HIV Protease Inhibitors; Humans; Hypnotics and Sedatives; Metabolic Clearance Rate; Microsomes, Liver; Oxidoreductases, N-Demethylating; Ritonavir; Triazolam | 1999 |
Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Data Collection; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Humans; Itraconazole; Ketoconazole; Midazolam; Triazolam | 1999 |
Benzodiazepine metabolism: an analytical perspective.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam | 2008 |
7 trial(s) available for alprazolam and triazolam
Article | Year |
---|---|
Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty.
Topics: Adult; Aged; Aging; Alprazolam; Anti-Anxiety Agents; Brain; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Psychomotor Performance; Triazolam | 1990 |
The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology.
Topics: Adult; Alprazolam; Carbon Monoxide Poisoning; Clinical Trials as Topic; Coma; Double-Blind Method; Drug Overdose; Flumazenil; Humans; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Suicide, Attempted; Triazolam | 1990 |
Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Cimetidine; Drug Interactions; Female; Guanidines; Humans; Male; Metabolic Clearance Rate; Middle Aged; Triazolam | 1983 |
Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Male; Mental Recall; Metabolic Clearance Rate; Piperazines; Psychomotor Performance; Triazolam; Triazoles | 1995 |
Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Area Under Curve; Chromatography, High Pressure Liquid; GABA Modulators; Half-Life; Humans; Male; Smoking; Triazolam | 1997 |
Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
Topics: Administration, Oral; Adult; Alprazolam; Antifungal Agents; Area Under Curve; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Hypnotics and Sedatives; Ketoconazole; Male; Reference Values; Time Factors; Triazolam | 1998 |
In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Biological Availability; Cytochrome P-450 CYP3A; Female; Humans; Male; Midazolam; Oxidoreductases, N-Demethylating; Triazolam | 2004 |
70 other study(ies) available for alprazolam and triazolam
Article | Year |
---|---|
Synthesis and pharmacology of novel anxiolytic agents derived from 2-[(dialkylamino)methyl-4H-triazol-4-yl] benzophenones and related heterocyclic benzophenones.
Topics: Animals; Anti-Anxiety Agents; Benzophenones; Drug Synergism; Electroshock; Ethanol; Male; Mice; Nicotine; Pentylenetetrazole; Semicarbazides; Strychnine; Triazoles | 1976 |
Novel anxiolytic agents derived from alpha-amino-alpha-phenyl-o-tolyl-4H-triazoles and -imidazoles.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Brain; Crystallography; Hypnotics and Sedatives; Imidazoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Models, Molecular; Molecular Conformation; Muscle Relaxation; Nicotine; Pentylenetetrazole; Rats; Seizures; Semicarbazides; Triazoles | 1978 |
Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Hydroxylation; Male; Methods; Mice; Oxidation-Reduction; Triazolam; Triazoles | 1978 |
6-Aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines. Influence of 1-substitution on pharmacological activity.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Body Temperature; Dextroamphetamine; Male; Mice; Motor Activity; Structure-Activity Relationship | 1979 |
Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF.
Topics: Amides; Animals; Female; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Urea | 1992 |
Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.
Topics: Animals; Female; Male; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Structure-Activity Relationship | 1992 |
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
Topics: Animals; Benzodiazepines; Brain; Cholecystokinin; Gastric Emptying; Gastric Mucosa; Guinea Pigs; Indicators and Reagents; Pancreas; Rats; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship; Triazoles | 1988 |
Amino acid amide derivatives of 2-[3-(aminomethyl)-4H-1,2,4-triazol-4-yl]benzophenones, a novel class of annelated peptidoaminobenzophenones.
Topics: Anesthesia; Animals; Anticonvulsants; Behavior, Animal; Benzophenones; Chemical Phenomena; Chemistry; Chlorprothixene; Drug Interactions; Hypnotics and Sedatives; Male; Mice; Motor Activity; Postural Balance; Thiopental | 1982 |
Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
Topics: Amides; Animals; Carbamates; Imides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Rabbits; Structure-Activity Relationship | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Topics: Alprazolam; Benzazepines; Benzodiazepines; Cell Cycle Proteins; GABA Modulators; Humans; Midazolam; Models, Molecular; Nuclear Proteins; Protein Interaction Maps; Protein Structure, Tertiary; Transcription Factors | 2012 |
Triazolam and platelet-aggregating factor.
Topics: Alprazolam; Blister; Humans; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Triazolam | 1992 |
High-performance liquid chromatographic method for the determination of alprazolam in plasma using the column-switching technique.
Topics: Aged; Alprazolam; Chromatography, High Pressure Liquid; Humans; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Triazolam | 1992 |
Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance.
Topics: Adult; Alprazolam; Benzodiazepines; Chlordiazepoxide; False Negative Reactions; Flunitrazepam; Fluorescence Polarization Immunoassay; Humans; Immunoenzyme Techniques; Lorazepam; Male; Middle Aged; Nitrazepam; Triazolam | 1992 |
The discriminative stimulus effects of diazepam in rats at two training doses.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Buspirone; Carbolines; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Flumazenil; Male; Morphine; Pentobarbital; Pyrazoles; Pyridazines; Rats; Rats, Inbred Strains; Triazolam | 1991 |
Possible mechanism for adverse reactions to triazolam.
Topics: Alprazolam; Anxiety; Humans; Platelet Activating Factor; Receptors, GABA-A; Substance Withdrawal Syndrome; Triazolam | 1991 |
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Clonazepam; Lorazepam; Male; Mice; Motor Activity; Nitrazepam; Oxazepam; Shyness; Structure-Activity Relationship; Triazolam | 1990 |
Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028.
Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Drug Implants; Mice; Mice, Inbred DBA; Receptors, GABA-A; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1990 |
Motor phenomena in benzodiazepine withdrawal.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Female; Humans; Muscle Rigidity; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Triazolam; Urinary Incontinence | 1989 |
Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
Topics: Alprazolam; Benzodiazepines; Benzophenones; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Immunoenzyme Techniques; Midazolam; Triazolam | 1989 |
Inhibition of the binding and the behavioral effects of thyrotropin-releasing hormone (TRH) by the triazolobenzodiazepines.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Estazolam; In Vitro Techniques; Mice; Pentobarbital; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone; Triazolam | 1988 |
Low-dose alprazolam augments motor activity in mice.
Topics: Alprazolam; Animals; Clonazepam; Exploratory Behavior; Flumazenil; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, GABA-A; Triazolam | 1988 |
Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam binding.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbolines; Clonazepam; Flunitrazepam; gamma-Aminobutyric Acid; Humans; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Triazolam | 1985 |
Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Cimetidine; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Time Factors; Triazolam | 1985 |
Comparative pharmacodynamics of benzodiazepines.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Triazolam | 1987 |
Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Brain; Cerebral Cortex; Estazolam; Flumazenil; Hippocampus; Hypothalamus; Kinetics; Male; Mice; Receptors, GABA-A; Triazolam | 1987 |
Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by triazolobenzodiazepines.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Biological Transport; Cell Membrane; Cerebral Cortex; Chlorides; Drug Interactions; gamma-Aminobutyric Acid; Male; Rats; Rats, Inbred Strains; Triazolam | 1988 |
[Pharmacologic characteristics of new triazolobenzodiazepine derivatives, triazolam and alprazolam].
Topics: Alprazolam; Animals; Behavior, Animal; Mice; Rats; Sleep; Triazolam | 1988 |
Triazolam withdrawal.
Topics: Alprazolam; Diazepam; Drug Tolerance; Humans; Seizures; Substance Withdrawal Syndrome; Triazolam | 1988 |
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.
Topics: Alprazolam; Binding, Competitive; Blood Platelets; Diazepam; Humans; In Vitro Techniques; Kinetics; Platelet Activating Factor; Platelet Aggregation; Triazolam | 1987 |
Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo.
Topics: Alprazolam; Animals; Azepines; Blood Pressure; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Injections, Intravenous; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Respiration; Triazolam | 1987 |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam.
Topics: Alprazolam; Animals; Blood Platelets; Furans; In Vitro Techniques; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Thiazoles; Triazolam | 1987 |
Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Half-Life; Humans; Triazolam | 1981 |
Determination of biological activity of alprazolam, triazolam and their metabolites.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Binding, Competitive; Brain; Diazepam; Flunitrazepam; Kinetics; Male; Membranes; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, GABA-A; Triazolam | 1982 |
Benzodiazepines: drug discrimination and physiological dependence.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Humans; Lorazepam; Papio; Pentobarbital; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1984 |
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Kinetics; Lorazepam; Smoking; Temazepam; Triazolam | 1984 |
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Topics: Adenosine Diphosphate; Alprazolam; Anti-Anxiety Agents; Arachidonic Acid; Arachidonic Acids; Benzodiazepines; Blood Platelets; Calcimycin; Chromatography, Gel; Collagen; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin; Triazolam | 1984 |
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam | 1995 |
Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood.
Topics: Alprazolam; Anti-Anxiety Agents; Cross Reactions; Humans; Immunoassay; Lorazepam; Nordazepam; Triazolam | 1993 |
Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein.
Topics: Acetylcholine; Alprazolam; Animals; Brain; Cerebral Cortex; GTP-Binding Proteins; Hippocampus; Norepinephrine; Platelet Activating Factor; Potassium; Rats; Serotonin; Tetrodotoxin; Triazolam; Tritium | 1994 |
Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells.
Topics: Alprazolam; Animals; Calcium; Cells, Cultured; Endothelium; Female; Kinetics; Kupffer Cells; Liver; Oxygen Consumption; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Triazolam; Verapamil | 1993 |
Tolerance to the anxiolytic effects of the triazolobenzodiazepines triazolam and alprazolam, as measured by the ingestion of a hypertonic sodium chloride solution in rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Drinking Behavior; Drug Tolerance; Male; Rats; Saline Solution, Hypertonic; Triazolam | 1996 |
Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Conflict, Psychological; Diazepam; Male; Maze Learning; Memory; Mice; Triazolam | 1997 |
Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Caffeine; Discrimination, Psychological; Female; GABA Agonists; GABA Modulators; Humans; Male; Phosphodiesterase Inhibitors; Pyridines; Triazolam; Zolpidem | 2001 |
Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys.
Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Diazepam; Macaca mulatta; Male; Reinforcement, Psychology; Self Administration; Triazolam | 2002 |
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Topics: Alprazolam; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clarithromycin; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes b5; Diltiazem; Estradiol; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Midazolam; Nifedipine; Tamoxifen; Testosterone; Triazolam | 2002 |
[Identification of estazolam, alprazolam and triazolam in human urine by LC/MSn].
Topics: Alprazolam; Anti-Anxiety Agents; Chromatography, Liquid; Estazolam; Humans; Male; Spectrometry, Mass, Electrospray Ionization; Triazolam | 2002 |
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators.
Topics: Alprazolam; Animals; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Agonists; GABA Modulators; Hypnosis; Hypnotics and Sedatives; Male; Medicine, Ayurvedic; Melatonin; Mice; Plant Extracts; Pyridines; Sleep; Sleep Initiation and Maintenance Disorders; Time Factors; Triazolam; Zolpidem | 2004 |
[Determination of alpha-hydroxytrizolam and alpha hydroxyaplrazolam from urine by acetylation derivatization using gas chromatography electron capture detection].
Topics: Acetylation; Adult; Alprazolam; Chromatography, Gas; Humans; Sensitivity and Specificity; Triazolam | 2004 |
There are no useful CYP3A probes that quantitatively predict the in vivo kinetics of other CYP3A substrates and no expectation that one will be found.
Topics: Alprazolam; Benzodiazepines; Biopharmaceutics; Chemistry, Pharmaceutical; Cytochrome P-450 CYP3A; Drug Design; Humans; Kinetics; Midazolam; Molecular Probes; Protein Binding; Solubility; Triazolam | 2005 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Cell Survival; Cells, Cultured; Cryopreservation; Cytochrome P-450 CYP3A; Diazepam; Flunitrazepam; Hepatocytes; Humans; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Substrate Specificity; Triazolam | 2008 |
Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice.
Topics: Administration, Oral; Alprazolam; Animals; Benzodiazepines; Biological Availability; Catheterization; Intestinal Mucosa; Jugular Veins; Liver; Male; Mice; Mice, Inbred BALB C; Midazolam; Portal Vein; Rats; Rats, Sprague-Dawley; Triazolam | 2009 |
Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Topics: Alprazolam; Benzodiazepines; Diazepam; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Nordazepam; Oxazepam; Solid Phase Extraction; Triazolam | 2010 |
LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Clonazepam; Flurazepam; Humans; Infant, Newborn; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazolam | 2010 |
Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.
Topics: Alprazolam; Benzodiazepines; Cytochrome P-450 CYP3A; Humans; Kinetics; Liver; Metabolic Clearance Rate; Midazolam; Triazolam | 2011 |
[Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine].
Topics: Alprazolam; Benzodiazepines; Biomarkers; Cross Reactions; Diazepam; Humans; Immunoassay; Nitrazepam; Reagent Kits, Diagnostic; Sensitivity and Specificity; Structure-Activity Relationship; Substance Abuse Detection; Triazolam | 2014 |
Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography-tandem mass spectrometry.
Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Flurazepam; Forensic Toxicology; Humans; Hypnotics and Sedatives; Limit of Detection; Pyridines; Tandem Mass Spectrometry; Triazolam; Zolpidem | 2015 |
A comparative study for detecting CYP3A induction by CYP3A probe drugs and endogenous markers in cynomolgus monkeys.
Topics: Alprazolam; Animals; Area Under Curve; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Drug Interactions; Hydrocortisone; Hydroxycholesterols; Macaca fascicularis; Male; Midazolam; Rifampin; Triazolam | 2019 |
Detailed quantum mechanical studies on bioactive benzodiazepine derivatives and their adsorption over graphene sheets.
Topics: Adsorption; Algorithms; Alprazolam; Benzodiazepines; Catalytic Domain; Chemistry, Pharmaceutical; Electrons; Estazolam; Graphite; Humans; Molecular Docking Simulation; Orexin Receptors; Quantum Theory; Relaxin; Serum Albumin, Human; Spectrophotometry; Triazolam | 2020 |
Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs.
Topics: Alprazolam; Animals; Benzodiazepines; Cytochrome P-450 CYP3A; Deoxycholic Acid; Dogs; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Midazolam; Protein Isoforms; Species Specificity; Steroids; Triazolam | 2022 |